Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
West Nile Virus
FDA approves Roche's cobas babesiosis test for blood donations
The in vitro screening test is designed for use with the company's 6800/8800 systems. Roche noted that the test is compliant with May 2019 guidance from the FDA regarding screening and testing blood donations for Babesia microti, a tick-borne, microscopic parasite that infects red blood cells.
September 19, 2019
Page 1 of 1
